468 related articles for article (PubMed ID: 19100344)
1. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
Ciprandi G; Contini P; Pistorio A; Murdaca G; Puppo F
Int Immunopharmacol; 2009 Feb; 9(2):253-7. PubMed ID: 19100344
[TBL] [Abstract][Full Text] [Related]
2. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
[TBL] [Abstract][Full Text] [Related]
3. Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
Ciprandi G; Colombo BM; Contini P; Cagnati P; Pistorio A; Puppo F; Murdaca G
Allergy; 2008 Oct; 63(10):1335-8. PubMed ID: 18782112
[TBL] [Abstract][Full Text] [Related]
4. Soluble serum HLA-G and HLA-A, -B, -C molecules in patients with seasonal allergic rhinitis exposed to pollens.
Ciprandi G; Contini P; Murdaca G; DeAmici M; Gallina AM; Puppo F
Int Immunopharmacol; 2009 Aug; 9(9):1058-62. PubMed ID: 19410660
[TBL] [Abstract][Full Text] [Related]
5. Soluble serum HLA-G in children with allergic rhinitis and asthma.
Ciprandi G; De Amici M; Caimmi S; Marseglia A; Marchi A; Castellazzi AM; Marseglia G
J Biol Regul Homeost Agents; 2010; 24(2):221-4. PubMed ID: 20487636
[TBL] [Abstract][Full Text] [Related]
6. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F
Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
[TBL] [Abstract][Full Text] [Related]
7. Soluble HLA-G molecule in patients with perennial allergic rhinitis.
Ciprandi G; Contini P; Murdaca G; Gallina AM; Puppo F
Int Arch Allergy Immunol; 2009; 150(3):278-81. PubMed ID: 19494525
[TBL] [Abstract][Full Text] [Related]
8. Two year sublingual immunotherapy affects serum leptin.
Ciprandi G; De Amici M; Tosca M; Negrini S; Murdaca G; Marseglia GL
Int Immunopharmacol; 2009 Sep; 9(10):1244-6. PubMed ID: 19497390
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta and IL-17 serum levels and specific immunotherapy.
Ciprandi G; De Amici M; Negrini S; Marseglia G; Tosca MA
Int Immunopharmacol; 2009 Sep; 9(10):1247-9. PubMed ID: 19622397
[TBL] [Abstract][Full Text] [Related]
10. Serum IL-4 as a marker of immunological response to sublingual immunotherapy.
Ciprandi G; De Amici M; Murdaca G; Colombo BM; Quaglini S; Marseglia G; Di Gioacchino M
J Biol Regul Homeost Agents; 2008; 22(2):117-23. PubMed ID: 18597704
[TBL] [Abstract][Full Text] [Related]
11. Sublingual immunotherapy provides an early increase of interferon-gamma production.
Ciprandi G; Fenoglio D; Di Gioacchino M; Ferrera A; Ferrera F; Sormani MP; Marseglia GL
J Biol Regul Homeost Agents; 2008; 22(3):169-73. PubMed ID: 18842170
[TBL] [Abstract][Full Text] [Related]
12. Serum transforming growth factor-beta levels depend on allergen exposure in allergic rhinitis.
Ciprandi G; De Amici M; Tosca M; Marseglia G
Int Arch Allergy Immunol; 2010; 152(1):66-70. PubMed ID: 19940507
[TBL] [Abstract][Full Text] [Related]
13. Carry-over effect on IFN-gamma production induced by allergen-specific immunotherapy.
Ciprandi G; Sormani MP; Filaci G; Fenoglio D
Int Immunopharmacol; 2008 Dec; 8(12):1622-5. PubMed ID: 18691675
[TBL] [Abstract][Full Text] [Related]
14. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
[TBL] [Abstract][Full Text] [Related]
15. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
Savolainen J; Jacobsen L; Valovirta E
Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
Smith H; White P; Annila I; Poole J; Andre C; Frew A
J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
[TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy may affect serum neopterin: preliminary findings.
Ciprandi G; De Amici M; Marseglia G; Fuchs D
Int Immunopharmacol; 2010 Nov; 10(11):1474-6. PubMed ID: 20863918
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen-G and regulatory T cells during specific immunotherapy for pollen allergy.
Sørensen AE; Johnsen CR; Dalgaard LT; Würtzen PA; Kristensen B; Larsen MH; Ullum H; Søes-Petersen U; Hviid TV
Int Arch Allergy Immunol; 2013; 162(3):237-52. PubMed ID: 24022071
[TBL] [Abstract][Full Text] [Related]
20. Sublingual immunotherapy affects specific antibody and TGF-beta serum levels in patients with allergic rhinitis.
Ciprandi G; De Amici M; Tosca MA; Pistorio A; Marseglia GL
Int J Immunopathol Pharmacol; 2009; 22(4):1089-96. PubMed ID: 20074473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
